2013 Biotechnology & Standards Conference: Agenda

Event Details

Location:
The MIT Media Lab, 75 Amherst Street, 6th Floor, Cambridge, MA 02139

Date:
Tuesday, October 1, 2013

Welcome & Introduction  (8:30 AM – 8:45 AM)

 

Stacy L. Springs
Director, Biomanufacturing Research Program
Executive Director, Consortium on Adventitious Agent Contamination in Biomanufacturing
Director, MIT-Sanofi Alliance, Center for Biomedical Innovation

Leonard Freedman
President, Global Biological Standards Institute
Chief Scientific Officer, American Type Culture Collection

Scott Stern
School of Management Distinguished Professor
Chair of the Technological Innovation, Entrepreneurship, and Strategic Management Group
MIT Sloan of School of Management

Standards in the Life Sciences: Prospects and Challenges (8:45 AM – 9:45 AM)

In this panel discussion, members of academia and Standard Development Organizations (SDOs) will discuss the prospects and the challenges of standards in biotechnology. What are standards in the life sciences and why are they important? How can standards facilitate better translation of basic biological research and enhance translational and regulatory sciences?

Leonard Freedman
President, Global Biological Standards Institute
Chief Scientific Officer, American Type Culture Collection

Carolyn Compton
Professor of Life Sciences, Arizona State University

Mary Lou Gantzer
President, Clinical and Laboratory Standards Institute

Moderated by Pierre Azoulay
Sloan Distinguished Associate Professor of Technological Innovation, Entrepreneurship, and Strategic Management MIT Sloan School of Management

Break (9:45 AM – 10:00 AM)

Biomaterials Standards: Challenges and Opportunities (10:00 AM – 11:00 AM)

During this panel discussion, experts will discuss the key challenges and opportunities for biomaterial standards in translational cancer research, cell therapy, and in the responsible sharing of genomic and clinical data. A growing concern in life sciences research is reproducibility of preclinical research findings. How can standards help assure that biomaterials such as cell lines used for cancer research or cell therapies used for regenerative medicine are authenticated? As we quickly approach an age where a human genome can be sequenced for $1000, what are the needs for management, interpretation, and integration of this data?

William E. Bentley
Robert E. Fischell Distinguished Professor and Chair of Bioengineering, University of Maryland

Brad A. Margus
CEO, Genome Bridge

John R. Masters
Professor of Experimental Pathology; Director, Prostate Cancer Research Centre, University College London

Leslie E. Silberstein
Director, Center for Human Cell Therapy; Director, Joint Program in Transfusion Medicine; Professor of Pathology Harvard Medical School

Moderated by Ron Weiss
Associate Professor of Biological Engineering and Electrical Engineering and Computer Science;
Director, Synthetic Biology Center, School of Engineering, MIT

Lessons from Other Industries (11:00 AM – 12:00 PM)

This panel will discuss how standards have been influential drivers of innovation and commercialization in a wide range of sectors, including information technology and software. A more proactive approach towards standard-setting in the life sciences can be informed by the experience and lessons of these sectors. What can we learn from the use of standards in areas such as the World Wide Web, or the Internet? What role do standard-setting organizations play in helping to translate university-based research into commercial products and services? How do standard-setting organizations manage disputes or conflicts over intellectual property?

Iain M. Cockburn
Richard C. Shipley Professor of Management, Boston University School of Management

Stuart Graham
Senior Advisor on Economic Policy, U.S. Patent & Trademark Office
Assistant Professor of Business Strategy, Scheller College of Business, Georgia Tech

Shane Greenstein
Kellogg Chair in Information Technology; Professor of Management and Strategy
Kellogg School of Management, Northwestern University

Timothy Simcoe
Associate Professor of Strategy and Innovation, Boston University School of Management
Faculty Research Fellow, National Bureau of Economic Research

Moderated by Fiona E. Murray
David Sarnoff Professor of Management of Technology
Associate Professor of Technological Innovation, Entrepreneurship. and Strategic Management
MIT Sloan School of Management
Faculty Director, Martin Trust Center for MIT Entrepreneurship

Lunch (12:00 PM – 1:00 PM)

Keynote Presentation (1:00 PM – 1:30 PM)

Raymond H Cypess
Chairman & CEO, American Type Culture Collection

The Case for Standards

Invited Presentations (1:30 PM – 2:45 PM)

Tom Dedeurwaerdere 
Professor, Université catholique de Louvain; Director, Biodiversity Governance (BIOGOV) Unit
Centre for the Philosophy of Law, Université catholique de Louvain

Microbial Commons: Community driven standards for digitally integrated life science research

Véronique Kiermer
Executive Editor and Head of Researcher Services, Nature Publishing Group

Reporting Standards to Reduce Irreproducibility: A journal’s perspective

Organizing for Life Sciences Standard-Setting & Closing (2:45 PM – 3:00 PM)

Scott Stern
School of Management Distinguished Professor
Chair of the Technological Innovation, Entrepreneurship, and Strategic Management Group
MIT Sloan of School of Management

Adjourn (3:00 PM)

Keynote
American Type Culture Collection
Hosts